Skip to ContentSkip to Navigation
Research Medical Microbiology
University Medical Center Groningen

PhD ceremony Ms. J.M. da Silva Voorham: Immature dengue virus: functional properties and potential contribution to disease

Immature dengue virus: functional properties and potential contribution to disease
15 May 2013

PhD ceremony: Ms. J.M. da Silva Voorham, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Immature dengue virus: functional properties and potential contribution to disease

Promotor(s): prof. J.M. Smit, prof. J.C. Wilschut

Faculty: Medical Sciences


Dengue virus (DENV) causes the most common mosquito-borne viral infection in the world. According to WHO estimates, 50-100 million dengue virus (DENV) infections occur annually in the subtropical and tropical regions of the world. DENV comprises four serotypes. Each of the serotypes can cause a spectrum of diseases, ranging from a febrile illness to a life-threatening hemorrhagic and vascular permeability syndrome. Most of the patients who develop severe disease have antibodies against different strains of the virus as a result of previous DENV infection episodes. These antibodies not only facilitate more efficient cellular uptake of virions, they also appear to modulate the immune response in infected cells thereby favoring virus particle production. This thesis describes that in the presence of antibodies, non-infectious immature DENV can become highly infectious with titers comparable to standard DENV preparations. During a heterologous secondary DENV infection - so in the presence of cross-reactive antibodies - immature virus particles can contribute to a higher virus titer and act as a co-factor in the pathogenesis of severe disease. In summary, these results show a better understanding of the mechanisms that are important in the process of DENV infection and development of disease. Moreover, these studies have potentially important implications for the development of antiviral agents and safe dengue vaccines.

Last modified:09 May 2019 11.27 a.m.
View this page in: Nederlands

More news

  • 29 November 2023

    UMCG opent nieuwe faciliteit voor microbioomonderzoek 

    Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...

  • 28 November 2023

    Science: more exciting than showbiz

    Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...

  • 13 November 2023

    UMCG beantwoordt vragen patiënten met hulp van AI

    Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...